Priapism and Penile Amputation

Priapism is a pathological, persistent, and often painful erection of the penis that occurs without sexual stimulation and fails to subside despite detumescence mechanisms. In veterinary medicine, priapism is a rare but serious condition primarily reported in dogs, with occasional cases in cats and horses. It is classified into two main types: low-flow (ischemic) priapism, which is the most common and constitutes a urological emergency due to the risk of irreversible cavernosal fibrosis and permanent erectile dysfunction, and high-flow (non-ischemic) priapism, which is typically less painful and associated with arterial trauma. Penile amputation, or penectomy, is a salvage surgical procedure indicated for severe priapism refractory to medical and surgical management, as well as for penile neoplasia, severe trauma, necrosis, or chronic fibrotic changes that render the organ nonfunctional. The surgical procedure involves partial or complete resection of the penis, with or without scrotal urethrostomy, to restore urinary function and alleviate pain. This entry provides an encyclopedic overview of priapism and penile amputation, covering etiology, pathophysiology, diagnostic workup, surgical techniques, and perioperative management.

The etiology of priapism in animals is multifactorial. In dogs, the most common causes include: 1) Neurogenic: spinal cord disease, trauma, or anesthesia-induced autonomic dysregulation. 2) Vascular: thrombosis or embolism of the cavernosal veins, often secondary to trauma or systemic disease. 3) Pharmacological: administration of drugs such as trazodone, prazosin, or other alpha-adrenergic antagonists, which can cause relaxation of cavernosal smooth muscle. 4) Neoplastic: infiltration of the penis or pelvic region by tumors (e.g., transitional cell carcinoma, squamous cell carcinoma, or metastatic lesions) that obstruct venous outflow. 5) Hematologic: hyperviscosity syndromes (e.g., polycythemia, leukemia) or coagulopathies leading to sludging in the cavernosal sinuses. 6) Traumatic: blunt perineal or pelvic trauma causing arterial-venous fistulas (high-flow priapism) or venous thrombosis. In cats, priapism is extremely rare but has been associated with urethral obstruction and feline lower urinary tract disease. In horses, priapism is often a complication of general anesthesia, particularly with phenothiazine tranquilizers (e.g., acepromazine), or due to trauma to the penis or pelvic region. Penile amputation is indicated when priapism is irreversible, leading to necrosis, fibrosis, or severe pain, or when the underlying cause (e.g., neoplasia) requires radical resection.

Priapism is a rare condition in veterinary medicine, with limited epidemiological data. It is most commonly reported in dogs, particularly in young to middle-aged males, with no strong breed predisposition, although some reports suggest a higher incidence in large-breed dogs. In horses, priapism is a well-recognized complication of general anesthesia, with an estimated incidence of 0.1-1% in equine surgeries, especially when acepromazine is used. Cats are rarely affected. Penile amputation is more frequently performed for penile neoplasia, which is uncommon but has been reported in dogs (e.g., squamous cell carcinoma, mast cell tumor, transmissible venereal tumor) and occasionally in cats. The age of onset for priapism varies, but it can occur at any age. There is no sex predilection beyond the male sex, as the condition is exclusive to males. Working dogs and those with a history of pelvic trauma may be at higher risk. The prognosis for priapism is guarded, with a high rate of permanent erectile dysfunction if not treated promptly.

The pathophysiology of priapism involves an imbalance between cavernosal arterial inflow and venous outflow, leading to persistent erection. In low-flow (ischemic) priapism, venous outflow obstruction or failure of detumescence mechanisms results in stagnant blood within the corpora cavernosa, leading to hypoxia, hypercapnia, acidosis, and ischemia. This ischemic environment causes endothelial damage, smooth muscle necrosis, and eventually fibrosis of the cavernosal tissue, which can be irreversible within 24-48 hours. The exact molecular mechanisms include depletion of nitric oxide, upregulation of hypoxia-inducible factor-1α, and increased expression of transforming growth factor-β, promoting collagen deposition and fibrosis. In high-flow (non-ischemic) priapism, usually caused by arterial trauma, unregulated arterial inflow into the cavernosal sinuses occurs, but venous outflow remains patent, so the tissue is not ischemic. This type is less painful and has a better prognosis. Penile amputation, when performed for priapism, removes the nonviable or fibrotic tissue, but the underlying systemic or neurological cause must be addressed to prevent recurrence. The surgical procedure also involves creating a permanent urethrostomy to allow urination, as the normal penile urethra is resected.

Predisposing factors for priapism include: 1) Breed and anatomical factors: certain breeds may have a higher incidence of penile or pelvic tumors, or a predisposition to spinal cord disease. 2) Age: young animals may be more prone to trauma, while older animals may have neoplastic causes. 3) Pharmacological: use of tranquilizers, especially phenothiazines in horses, and alpha-adrenergic antagonists in dogs. 4) Systemic diseases: coagulopathies, hyperviscosity syndromes, and sickle cell anemia (rare in animals). 5) Trauma: pelvic or perineal trauma can cause arterial-venous fistulas or venous thrombosis. 6) Neurological conditions: spinal cord lesions, intervertebral disc disease, or autonomic neuropathy. 7) Prior surgery: anesthesia-related priapism is a known complication in horses. For penile amputation, predisposing factors include the presence of penile neoplasia, chronic priapism with necrosis, or severe trauma that is not amenable to repair.

Clinical signs of priapism include a persistent, non-sexual erection that may be painful or non-painful depending on the type. The penis is engorged, firm, and may be protruded from the prepuce. The animal may show signs of discomfort, such as licking the area, straining to urinate, or vocalizing. In low-flow priapism, the penis may become cold, cyanotic, and eventually necrotic if not treated. Urination may be difficult or impossible due to the engorgement. In high-flow priapism, the penis may be less firm and less painful, and the animal may be able to urinate. Systemic signs may include lethargy, fever, and signs of underlying disease (e.g., neoplasia, spinal cord disease). On physical examination, the penis is palpably engorged, and the prepuce may be swollen. In chronic cases, there may be evidence of tissue necrosis, ulceration, or fibrosis. If penile amputation is performed, the animal will have a scrotal or perineal urethrostomy, and the owner should be aware of the cosmetic and functional changes.

Differential diagnoses for priapism include: 1) Normal erection: physiological erection occurs during sexual arousal and resolves with detumescence; priapism is persistent and unrelated to arousal. 2) Paraphimosis: the penis is protruded and cannot be retracted into the prepuce, but it is not necessarily erect; it is often due to preputial constriction or neurological deficits. 3) Penile trauma: swelling and hematoma may mimic priapism, but the penis is not typically erect. 4) Penile neoplasia: tumors may cause penile enlargement, but the penis is not erect; biopsy is diagnostic. 5) Urethral obstruction: may cause penile engorgement due to straining, but the penis is not erect. 6) Priapism due to spinal cord disease: may be accompanied by other neurological signs. 7) Drug-induced priapism: history of drug administration. 8) High-flow vs. low-flow priapism: differentiation is based on blood gas analysis of cavernosal blood and Doppler ultrasound. For penile amputation, differential diagnoses include conditions that may be treated with less radical surgery, such as penile trauma that can be repaired, or benign masses that can be excised locally.

The diagnostic workup for priapism should follow a systematic approach: 1) History and physical examination: assess the duration of erection, pain, and any underlying causes (trauma, drugs, neurological signs). 2) Cavernosal blood gas analysis: aspirate blood from the corpora cavernosa; low-flow priapism shows hypoxic, hypercapnic, acidotic blood (PO2 < 30 mmHg, PCO2 > 60 mmHg, pH < 7.25), while high-flow priapism shows arterial blood gases (PO2 > 90 mmHg, PCO2 < 40 mmHg, pH > 7.40). 3) Doppler ultrasound: assess cavernosal arterial flow; high-flow priapism shows increased arterial inflow, while low-flow shows minimal or absent flow. 4) Complete blood count, serum biochemistry, and coagulation profile: rule out hematologic causes. 5) Urinalysis: assess for hematuria or infection. 6) Imaging: abdominal and pelvic radiographs or ultrasound to identify masses, trauma, or spinal lesions. 7) Neurological examination: if spinal cord disease is suspected, consider MRI or CT of the spine. 8) If neoplasia is suspected, fine-needle aspiration or biopsy of the penis or regional lymph nodes. 9) In cases of priapism refractory to medical management, surgical exploration may be indicated. For penile amputation, the diagnostic algorithm includes staging of the underlying disease (e.g., tumor staging with thoracic radiographs and abdominal ultrasound) and assessment of the extent of penile involvement.

Laboratory findings in priapism may include: 1) Cavernosal blood gas analysis: as described above, is crucial for differentiating low-flow from high-flow priapism. 2) Complete blood count: may reveal leukocytosis if infection or inflammation is present, or polycythemia in hyperviscosity syndromes. 3) Serum biochemistry: may show elevated muscle enzymes (creatine kinase) if tissue necrosis is extensive, or evidence of renal dysfunction if urinary obstruction has occurred. 4) Coagulation profile: prolonged PT/aPTT may indicate a coagulopathy. 5) Urinalysis: may show hematuria, pyuria, or crystalluria if concurrent urinary tract disease. 6) Inflammatory biomarkers: C-reactive protein (CRP) and serum amyloid A (SAA) may be elevated in inflammatory or necrotic conditions. 7) Cytology of any penile masses: may reveal neoplastic cells. 8) Histopathology of amputated penile tissue: will show ischemic necrosis, fibrosis, or neoplasia.

Imaging plays a key role in the diagnosis and management of priapism. 1) Radiography: plain radiographs of the pelvis and abdomen may identify fractures, masses, or foreign bodies. Contrast urethrography can assess the urethra. 2) Ultrasonography: Doppler ultrasound of the penis is essential to assess blood flow in the corpora cavernosa. In low-flow priapism, there is minimal or absent flow; in high-flow, there is turbulent arterial flow. Ultrasound can also identify masses, hematomas, or abscesses. 3) CT: computed tomography with contrast can provide detailed images of the penile vasculature and identify arterial-venous fistulas or thrombosis. It is also useful for staging pelvic tumors. 4) MRI: magnetic resonance imaging is excellent for soft tissue detail and can assess the extent of fibrosis or necrosis in the corpora cavernosa. It is also useful for evaluating spinal cord lesions. 5) Angiography: selective pudendal arteriography can identify the source of arterial inflow in high-flow priapism and guide embolization. 6) Fluoroscopy: may be used during interventional procedures such as embolization.

Cytology and histopathology are important in the diagnosis of underlying causes and in the evaluation of amputated tissue. 1) Fine-needle aspiration of penile masses: cytology can identify neoplastic cells (e.g., squamous cell carcinoma, mast cell tumor, transmissible venereal tumor). 2) Cavernosal blood aspiration: may show red blood cells with no specific cytological features, but blood gas analysis is more informative. 3) Histopathology of amputated penile tissue: in priapism, the tissue shows ischemic necrosis, hemorrhage, and fibrosis. In neoplasia, the tumor type and surgical margins are evaluated. Special stains (e.g., Masson's trichrome for fibrosis, immunohistochemistry for tumor markers) may be used. 4) Biopsy of regional lymph nodes: if metastasis is suspected.

Treatment of priapism depends on the type and duration. Initial medical management includes: 1) Sedation and analgesia: use of opioids (e.g., morphine 0.5-1 mg/kg IM or IV) and tranquilizers (e.g., acepromazine 0.02-0.05 mg/kg IV) to reduce sympathetic tone. 2) Cavernosal aspiration and irrigation: aspirate blood from the corpora cavernosa and irrigate with saline or a dilute alpha-agonist solution (e.g., phenylephrine 10-20 µg/kg diluted in saline). This is the first-line treatment for low-flow priapism. 3) Alpha-adrenergic agonists: phenylephrine (10-20 µg/kg) or epinephrine (1-2 µg/kg) can be injected intracavernosally to cause vasoconstriction. 4) Systemic alpha-agonists: oral or parenteral phenylpropanolamine (1-2 mg/kg PO q8h) may be used. 5) Treatment of underlying cause: discontinue offending drugs, treat hematologic disorders, or manage neurological disease. If medical management fails within 24-48 hours, surgical intervention is indicated. Surgical options include: 1) Cavernosal shunt procedures: creation of a shunt between the corpora cavernosa and the corpus spongiosum (e.g., Winter's shunt, Al-Ghorab shunt) to allow drainage of stagnant blood. 2) Penile amputation: if the penis is necrotic or fibrotic, or if the animal is not a candidate for shunt surgery. Penile amputation involves resection of the penis and creation of a scrotal or perineal urethrostomy. The surgical technique for penile amputation: 1) Position the animal in dorsal recumbency. 2) Catheterize the urethra. 3) Make a circumferential incision around the prepuce and dissect the penis free from the surrounding tissue. 4) Ligate the dorsal penile vessels and the corpus cavernosum. 5) Transect the penis at the level of the ischial arch. 6) Create a scrotal urethrostomy by incising the urethra and suturing it to the skin. 7) Close the subcutaneous tissue and skin. Postoperative care includes pain management, antibiotics, and Elizabethan collar to prevent self-trauma.

The prognosis for priapism depends on the duration and type. High-flow priapism has a better prognosis, with spontaneous resolution or successful embolization. Low-flow priapism has a guarded prognosis, especially if treatment is delayed beyond 24-48 hours, as irreversible fibrosis may occur. Even with successful detumescence, permanent erectile dysfunction may result. Penile amputation is a salvage procedure that resolves the immediate problem but results in permanent loss of reproductive function and altered urinary anatomy. The prognosis for the underlying disease (e.g., neoplasia) must be considered. Overall, the short-term prognosis for survival is good if the animal is treated promptly, but long-term quality of life depends on the underlying cause and the success of urinary diversion.

Follow-up care after treatment of priapism or penile amputation includes: 1) Immediate postoperative monitoring: assess urination, surgical site, and pain. 2) Suture removal: skin sutures are typically removed in 10-14 days. 3) Serial examinations: recheck at 2, 4, and 8 weeks postoperatively to assess healing and urinary function. 4) If a urethrostomy was performed, monitor for stricture or infection. 5) If the underlying cause was neoplasia, perform regular staging (thoracic radiographs, abdominal ultrasound) every 3-6 months. 6) If the animal is intended for breeding, discuss the loss of reproductive capability. 7) Long-term monitoring for recurrence of priapism if the underlying cause is not resolved.

Clinical pearls: 1) Early diagnosis and treatment of low-flow priapism is critical to prevent permanent damage. 2) Cavernosal blood gas analysis is essential to differentiate low-flow from high-flow priapism. 3) In horses, avoid phenothiazine tranquilizers in breeding stallions. 4) When performing penile amputation, ensure adequate hemostasis and create a tension-free urethrostomy. 5) Use a urinary catheter to guide the urethrostomy. Pitfalls: 1) Delaying surgical intervention in low-flow priapism can lead to irreversible fibrosis. 2) Inadequate irrigation or alpha-agonist therapy may fail to achieve detumescence. 3) In penile amputation, failure to ligate the corpus cavernosum can lead to hemorrhage. 4) Urethrostomy stricture is a common complication if the mucosa is not apposed to the skin properly. 5) Overlooking an underlying systemic disease (e.g., neoplasia) can lead to recurrence or poor outcome.

Perioperative drug protocols for priapism and penile amputation are based on Plumb's Veterinary Drug Handbook. 1) Preoperative antibiotics: cefazolin (22 mg/kg IV) or ampicillin (20 mg/kg IV) administered 30 minutes before incision, repeated every 90 minutes during surgery. 2) Postoperative antibiotics: amoxicillin-clavulanic acid (13.75 mg/kg PO q12h) for 7-10 days. 3) Analgesia: opioids such as morphine (0.5-1 mg/kg IM or IV q4-6h) or fentanyl CRI (2-5 µg/kg/h) for the first 24 hours. 4) NSAIDs: carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) for 3-5 days, with caution in renal or hepatic disease. 5) For priapism: phenylephrine (10-20 µg/kg) intracavernosal, repeated every 5-10 minutes up to 3 doses. 6) Sedatives: acepromazine (0.02-0.05 mg/kg IV) or diazepam (0.2-0.5 mg/kg IV) to reduce anxiety. 7) If infection is present, culture and sensitivity should guide antibiotic selection. 8) For urethrostomy, consider topical lidocaine gel for pain management. 9) Anticholinergics (e.g., atropine) are not routinely used but may be needed for bradycardia.

The veterinary literature on priapism is limited to case reports and small case series. In dogs, the most common causes are neurogenic and pharmacological. A retrospective study by Papazoglou et al. (2003) reported 5 cases of priapism in dogs, with successful management using cavernosal aspiration and phenylephrine in 3 cases, and penile amputation in 2 cases. In horses, a study by Wilson et al. (1991) reported that acepromazine-induced priapism could be managed with phenylephrine and aspiration, but severe cases required surgical intervention. The use of penile amputation for penile neoplasia is well-documented, with a study by Sontas et al. (2010) reporting good outcomes in dogs with transmissible venereal tumor. There are no randomized controlled trials due to the rarity of the condition. Consensus guidelines from the American College of Veterinary Surgeons (ACVS) recommend early aggressive management of low-flow priapism to prevent fibrosis. The prognosis for high-flow priapism is generally good, with spontaneous resolution or successful embolization. Overall, the evidence supports a stepwise approach: medical management first, followed by surgical shunts, and finally penile amputation as a salvage procedure.